Efficacy and Safety of Intravenously Administered Iron Sucrose With and Without Adjuvant Recombinant Human Erythropoietin for the Treatment of Resistant Iron-Deficiency Anemia During Pregnancy
American Journal of Obstetrics and Gynecology - United States
doi 10.1067/mob.2001.111717
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2001
Authors
Publisher
Elsevier BV